Palladio Biosciences
Palladio Biosciences develops transformative medicines for orphan diseases of the kidney.
Funding reportedLast round: Series B
What company datasets say Palladio Biosciences raised
Funding, as reported
Reported in all20Min the source's currency
Rounds2
Last roundSeries B
Last round dateSept 2020
Investors listed4
Biotechnology in the same market
Startups like it
Is this your company?
Add your raise, your deck and your story, and put Palladio Biosciences in front of investors. Or tell us what we have wrong.